Skip to content

ORTHOPEDIC: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ORTHOPEDIC

BE 0433.672.449
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€13,809
2024 · €16,763-€2,953
Equity
€91,098
2024 · €77,288+€13,809
Cash
€99,333
2024 · €27,474+€71,859
Balance sheet total
€557,299
2024 · €483,855+€73,445

Largest movements

2024 to 2025
Assets
  • Cash +€71,859

    up €71,859 (+262%), from €27,474 to €99,333

    mainly Short-term financial debts (+€126,450) and Depreciation (+€35,906)

  • Tangible fixed assets -€26,688

    down €26,688 (-15.8%), from €168,438 to €141,751

    of which Plant, machinery and equipment: -€25,440

  • Formation expenses +€20,281

    new in 2025: €20,281

  • Deferred charges and accrued income +€11,084

    up €11,084 (+524%), from €2,115 to €13,199

  • Intangible fixed assets +€5,718

    up €5,718 (+97.5%), from €5,867 to €11,584

Equity and liabilities
  • Short-term financial debts +€126,450

    up €126,450 (+84.3%), from €150,000 to €276,450

  • Debts after one year -€26,592

    down €26,592 (-62.2%), from €42,749 to €16,157

  • Current portion of long-term debt -€25,283

    no longer reported in 2025 (was €25,283)

  • Trade debts -€16,598

    down €16,598 (-62.4%), from €26,619 to €10,021

  • Profit (loss) carried forward +€13,809

    up €13,809 (+12.9%), from -€107,162 to -€93,352

Income statement
  • Other operating charges +€10,317

    up €10,317 (+93.1%), from €11,082 to €21,399

  • Gross operating margin +€6,809

    up €6,809 (+8.5%), from €80,435 to €87,244

  • Financial income +€5,755

    up €5,755 (+1,619%), from €356 to €6,111

  • Financial charges +€5,062

    up €5,062 (+29.5%), from €17,178 to €22,240

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €16,763
Gross operating margin +€6,809
Depreciation -€138
Other operating charges -€10,317
Financial income +€5,755
Financial charges -€5,062
Result 2025 €13,809
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€32,501
Investment -€35,216
Financing +€74,575
Cash 2024 €27,474
Net result for the year +€13,809
Depreciation +€35,906
Stocks and contracts +€4,253
Receivables within one year +€4,557
Deferred charges and accrued income -€11,084
Trade debts -€16,598
Tax, wage and social debts +€1,658
Investment in fixed assets (net) -€35,216
Debts after one year -€26,592
Current portion of long-term debt -€25,283
Short-term financial debts +€126,450
Cash 2025 €99,333
brings cash intakes cash out
Every line side by side 55 lines
Line Code 2024 2025 Change %
Total assets 20/58 €483,855 €557,299 +€73,445 +15.2%
Formation expenses 20 - €20,281 +€20,281
Fixed assets 21/28 €174,305 €153,335 -€20,970 -12.0%
Intangible fixed assets 21 €5,867 €11,584 +€5,718 +97.5%
Tangible fixed assets 22/27 €168,438 €141,751 -€26,688 -15.8%
Land and buildings 22 €74,368 €74,368 = 0.0%
Plant, machinery and equipment 23 €85,487 €60,047 -€25,440 -29.8%
Furniture and vehicles 24 €8,584 €7,336 -€1,248 -14.5%
Other tangible fixed assets 26 €0 - =
Current assets 29/58 €309,550 €383,684 +€74,134 +23.9%
Stocks and contracts in progress 3 €115,524 €111,271 -€4,253 -3.7%
Stocks 30/36 €115,524 €111,271 -€4,253 -3.7%
Amounts receivable within one year 40/41 €164,437 €159,880 -€4,557 -2.8%
Trade receivables 40 €40,305 €72,864 +€32,559 +80.8%
Other amounts receivable 41 €124,132 €87,016 -€37,116 -29.9%
Cash at bank and in hand 54/58 €27,474 €99,333 +€71,859 +262%
Deferred charges and accrued income 490/1 €2,115 €13,199 +€11,084 +524%
Total equity and liabilities 10/49 €483,855 €557,299 +€73,445 +15.2%
Equity 10/15 €77,288 €91,098 +€13,809 +17.9%
Contributions 10/11 €61,500 €61,500 = 0.0%
Capital 10 €61,500 €61,500 = 0.0%
Issued capital 100 €61,500 €61,500 = 0.0%
Reserves 13 €122,950 €122,950 = 0.0%
Non-distributable reserves 130/1 €6,150 €6,150 = 0.0%
Legal reserve 130 €6,150 €6,150 = 0.0%
Tax-exempt reserves 132 €6,000 €6,000 = 0.0%
Distributable reserves 133 €110,800 €110,800 = 0.0%
Profit (loss) carried forward 14 -€107,162 -€93,352 +€13,809 +12.9%
Provisions and deferred taxes 16 €148,884 €148,884 = 0.0%
Provisions for liabilities and charges 160/5 €148,884 €148,884 = 0.0%
Other liabilities and charges 164/5 €148,884 €148,884 = 0.0%
Amounts payable 17/49 €257,682 €317,318 +€59,635 +23.1%
Amounts payable after more than one year 17 €42,749 €16,157 -€26,592 -62.2%
Financial debts 170/4 €42,749 €16,157 -€26,592 -62.2%
Amounts payable within one year 42/48 €214,933 €301,161 +€86,228 +40.1%
Current portion of amounts payable after more than one year 42 €25,283 - -€25,283
Financial debts 43 €150,000 €276,450 +€126,450 +84.3%
Credit institutions 430/8 €150,000 €276,450 +€126,450 +84.3%
Trade debts 44 €26,619 €10,021 -€16,598 -62.4%
Suppliers 440/4 €26,619 €10,021 -€16,598 -62.4%
Taxes, remuneration and social security 45 €13,031 €14,689 +€1,658 +12.7%
Taxes 450/3 €13,031 €14,689 +€1,658 +12.7%
Other amounts payable 47/48 €0 - =
Accrued charges and deferred income 492/3 €0 - =
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €35,768 €35,906 +€138 +0.4%
Other operating charges 640/8 €11,082 €21,399 +€10,317 +93.1%
Gross operating margin 9900 €80,435 €87,244 +€6,809 +8.5%
Operating profit (loss) 9901 €33,585 €29,939 -€3,647 -10.9%
Financial income 75/76B €356 €6,111 +€5,755 +1,619%
Recurring financial income 75 €356 €6,111 +€5,755 +1,619%
Financial charges 65/66B €17,178 €22,240 +€5,062 +29.5%
Recurring financial charges 65 €17,178 €22,240 +€5,062 +29.5%
Profit (loss) for the period before taxes 9903 €16,763 €13,809 -€2,953 -17.6%
Profit (loss) for the period 9904 €16,763 €13,809 -€2,953 -17.6%
Profit (loss) for the period to be appropriated 9905 €16,763 €13,809 -€2,953 -17.6%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.